Kevin P. Nanry

723 total citations
23 papers, 603 citations indexed

About

Kevin P. Nanry is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Kevin P. Nanry has authored 23 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 7 papers in Psychiatry and Mental health and 6 papers in Molecular Biology. Recurrent topics in Kevin P. Nanry's work include Neuroscience and Neuropharmacology Research (8 papers), Bipolar Disorder and Treatment (6 papers) and Memory and Neural Mechanisms (4 papers). Kevin P. Nanry is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Bipolar Disorder and Treatment (6 papers) and Memory and Neural Mechanisms (4 papers). Kevin P. Nanry collaborates with scholars based in United States. Kevin P. Nanry's co-authors include Hugh A. Tilson, H.A. Tilson, Jau‐Shyong Hong, Pearlie M. Hudson, William R. Mundy, Michal K. Stachowiak, Ronnie L. McLamb, Lisa Williams, Wilkie A. Wilson and Thomas R. Thompson and has published in prestigious journals such as Brain Research, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Kevin P. Nanry

23 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin P. Nanry United States 12 428 162 140 131 86 23 603
Robert C. Holley United States 13 429 1.0× 166 1.0× 137 1.0× 92 0.7× 34 0.4× 16 613
B. D. Kretschmer Germany 17 633 1.5× 256 1.6× 188 1.3× 195 1.5× 56 0.7× 26 851
Ana Hitri United States 16 386 0.9× 203 1.3× 79 0.6× 79 0.6× 129 1.5× 30 585
Xingjie Ping United States 15 332 0.8× 178 1.1× 118 0.8× 64 0.5× 115 1.3× 37 618
Robert H. Roth United States 11 429 1.0× 170 1.0× 161 1.1× 50 0.4× 22 0.3× 12 573
Gerard D. Pratt United Kingdom 12 415 1.0× 237 1.5× 55 0.4× 51 0.4× 85 1.0× 13 608
Thomas B. Wishart Canada 16 305 0.7× 103 0.6× 126 0.9× 40 0.3× 46 0.5× 31 504
Fredric B. Weihmuller United States 11 615 1.4× 239 1.5× 62 0.4× 145 1.1× 35 0.4× 13 693
M. Kodsi United States 9 457 1.1× 192 1.2× 246 1.8× 101 0.8× 43 0.5× 16 645
Alfred Hetzenauer Austria 12 448 1.0× 410 2.5× 145 1.0× 50 0.4× 80 0.9× 14 912

Countries citing papers authored by Kevin P. Nanry

Since Specialization
Citations

This map shows the geographic impact of Kevin P. Nanry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Nanry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Nanry more than expected).

Fields of papers citing papers by Kevin P. Nanry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Nanry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Nanry. The network helps show where Kevin P. Nanry may publish in the future.

Co-authorship network of co-authors of Kevin P. Nanry

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Nanry. A scholar is included among the top collaborators of Kevin P. Nanry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Nanry. Kevin P. Nanry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Patricia, et al.. (2017). Clinical trial conduct in special populations and developing regions: An overview of the DOVE study in pediatric patients with sickle cell disease. Contemporary Clinical Trials. 64. 88–94. 1 indexed citations
2.
Bolge, S., Thomas R. Thompson, Eric Bourne, & Kevin P. Nanry. (2008). Characteristics and Symptomatology of Patients Diagnosed with Unipolar Depression at Risk for Undiagnosed Bipolar Disorder: A Bipolar Survey. CNS Spectrums. 13(3). 216–224. 5 indexed citations
3.
Graham, Jay A., et al.. (2007). Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.. PubMed. 9(2). 41–41. 7 indexed citations
4.
Kaye, Neil, Jay A. Graham, Jeremy Roberts, Thomas R. Thompson, & Kevin P. Nanry. (2007). Effect of Open-Label Lamotrigine as Monotherapy and Adjunctive Therapy on the Self-Assessed Cognitive Function Scores of Patients With Bipolar I Disorder. Journal of Clinical Psychopharmacology. 27(4). 387–391. 12 indexed citations
5.
Sajatovic, Martha, Eugene Ramsay, Kevin P. Nanry, & Thomas R. Thompson. (2007). Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. International Journal of Geriatric Psychiatry. 22(10). 945–950. 22 indexed citations
6.
Bourne, Eric, A A Nierenberg, John Geddes, et al.. (2006). Lamotrigine for acute treatment of bipolar depression: A retrospective pooled analysis of response rates in 3 randomized trials. The International Journal of Neuropsychopharmacology. 9. 1 indexed citations
7.
Ketter, Terence A., John H. Greist, James A. Graham, et al.. (2006). The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder. The Journal of Clinical Psychiatry. 67(3). 400–406. 19 indexed citations
8.
Kustra, Robert P., Kimford J. Meador, Bradley K. Evans, et al.. (2005). Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen. Seizure. 14(4). 254–261. 8 indexed citations
9.
Nanry, Kevin P., Gerald T. Pollard, & James L. Howard. (1995). Olanzapine moderately increases conflict responding but does not produce a benzodiazepine‐like cue in rat. Drug Development Research. 34(3). 317–319. 9 indexed citations
10.
Nanry, Kevin P., et al.. (1992). Effects of tandospirone in three behavioral tests for anxiolytics. European Journal of Pharmacology. 221(2-3). 297–305. 16 indexed citations
11.
Nanry, Kevin P., James L. Howard, & Gerald T. Pollard. (1991). Effects of buspirone and other anxiolytics on punished key‐pecking in the pigeon. Drug Development Research. 24(3). 269–276. 10 indexed citations
12.
Tandon, Poonam, et al.. (1991). Age-dependent changes in receptor-stimulated phosphoinositide turnover in the rat hippocampus. Pharmacology Biochemistry and Behavior. 38(4). 861–867. 30 indexed citations
13.
McLamb, Ronnie L., Lisa Williams, Kevin P. Nanry, Wilkie A. Wilson, & Hugh A. Tilson. (1990). MK-801 impedes the acquisition of a spatial memory task in rats. Pharmacology Biochemistry and Behavior. 37(1). 41–45. 87 indexed citations
14.
Jiang, Hongquan, et al.. (1990). Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Molecular Brain Research. 8(3). 219–225. 95 indexed citations
15.
Nanry, Kevin P., William R. Mundy, & Hugh A. Tilson. (1989). Colchicine-induced alterations of reference memory in rats: role of spatial versus non-spatial task components. Behavioural Brain Research. 35(1). 45–53. 49 indexed citations
16.
Nanry, Kevin P. & Hugh A. Tilson. (1989). The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats. Psychopharmacology. 97(4). 507–513. 42 indexed citations
17.
Tilson, H.A., et al.. (1988). Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Brain Research. 461(2). 335–342. 127 indexed citations
18.
Tilson, H.A., G. Jean Harry, Kevin P. Nanry, Pearlie M. Hudson, & Jau‐Shyong Hong. (1988). Ganglioside interactions with the dopaminergic system of rats. Journal of Neuroscience Research. 19(1). 88–93. 33 indexed citations
19.
Nanry, Kevin P., et al.. (1985). Supra-additive toxic interaction of nicotine with antihistamines, and enhancement by the proconvulsant pentylenetetrazole. Pharmacology Biochemistry and Behavior. 22(3). 469–477. 1 indexed citations
20.
Nanry, Kevin P., et al.. (1982). Prednisolone effects upon body and organ weights, water intake, and several behaviors. Pharmacology Biochemistry and Behavior. 17(6). 1225–1231. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026